from2028 Activists Investors Trump Politicians Serenity Citrini Burry Semianalysis Swing Trade Arbitrage Search

$LQDA:NASDAQ · LIQUIDIA CORPORATION

Sector: health

Conviction from: NASDAQ

52-week range: 21.1493.61

Inhaled-therapy biopharma (pulmonary hypertension)

2 tracked filer(s) hold this · 1 opened, 0 added, 1 trimmed in 30-JUN-2026

Aggregate 13FScore 72 — mean of 2 scored holder(s) · buyers (new/add) avg 80. Higher = the smart money in this name has the better track record.

Filer	13FScore	This quarter	Shares	Value	% of their book
Steve Cohen / Point72	80	New buy	2,800	$223,244	0.0%
Paul Tudor Jones / Tudor	63	Trimmed -65%	16,400	$1,307,572	0.0%

Beyond 13F — activists, insiders, politicians & research

Insider open-market buys daily digest →

Filed	Insider	Role	Shares	Value
2026-05-20	Caligan Partners LP	director+10%-owner	5,300	$317,894	Form 4

Every tracked holder of this name, sorted new → added → flat → trimmed. Shares = reported 13F share count; Value as reported (a few managers file values in $thousands). Generated 2026-08-17.